# Synbody Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synbody-biotechnology

- Industry: Biotechnology
- Headquarters: Farmington, US
- Website: www.synbodybio.com
- Total disclosed funding: $0.8M
- Latest round: Seed (Mar 17, 2012)
- Investors on record: 1

## About

Based in Connecticut, US, Synbody Biotechnology (SBI) is a start-up biotechnology company. IT is leveraging a revolutionary platform for the discovery and development of novel and attractive molecules in the therapeutic, diagnostic, and proteomic technology fields. Synbody technology is the first biopharmaceutical platform to capitalize on the recently recognized and important role of small flexible regions of proteins, termed molecular recognition features (MoRF), to mediate interactions with other proteins.

## Funding rounds

- Seed, Mar 17, 2012, $0.8M — Connecticut Innovations

## Investors

- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Seed